JAK2-positive Philadelphia-negative myeloproliferative neoplasms
The recent discovery of the JAK2 mutations has rekindled interest in the approach to classic BCR/ABL-negative myeloproliferative neoplasms (MPNs) in terms of both diagnostic evaluation and treatment. However, additional clinical, laboratory and histological parameters play a key role to allow diagno...
Saved in:
Main Authors: | Anjali Sharma (Author), Gurdeep Buxi (Author), Sadhna Marwah (Author), Rajbala Yadav (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms
by: Kanwaljeet Singh, et al.
Published: (2018) -
Circulating Cytokine Levels as Markers of Inflammation in Philadelphia Negative Myeloproliferative Neoplasms: Diagnostic and Prognostic Interest
by: Julie Mondet, et al.
Published: (2015) -
JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
by: Michael Stephan Bader, et al.
Published: (2022) -
Hairy cell leukemia: An unusual morphology
by: Sharma Anjali, et al.
Published: (2010) -
Falsely low HbA1c value due to a rare hemoglobin variant (HEMOGLOBIN J-MEERUT) - A family study
by: Anjali Sharma, et al.
Published: (2012)